Home / Inspections / 1028879

FDA Inspection 1028879 — Marlex Pharmaceuticals, Inc.

Marlex Pharmaceuticals, Inc. — FEI 1000121454

The FDA completed an inspection of Marlex Pharmaceuticals, Inc. on September 6, 2017 in New Castle, DE. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 6, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
New Castle, DE (United States)

Facility

Other inspections at this facility

  • 1291594 (VAI Fri Nov 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1169769 (NAI Thu Apr 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1148584 (VAI Thu Aug 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 931349 (NAI Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 741052 (NAI Wed Aug 24 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources